USD 129.75
(-0.75%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 90.95 Million USD | 40.93% |
2022 | 68.73 Million USD | 4.25% |
2021 | 65.93 Million USD | 48.15% |
2020 | 44.5 Million USD | 28.07% |
2019 | 34.75 Million USD | 43.02% |
2018 | 24.29 Million USD | -7.39% |
2017 | 26.23 Million USD | 72.23% |
2016 | 15.23 Million USD | -4.92% |
2015 | 16.02 Million USD | -11.33% |
2014 | 18.07 Million USD | 16.88% |
2013 | 15.46 Million USD | -1.29% |
2012 | 15.66 Million USD | 472.49% |
2011 | -4.2 Million USD | -135.07% |
2010 | 11.99 Million USD | 1.84% |
2009 | 11.77 Million USD | 8.55% |
2008 | 10.84 Million USD | 115.37% |
2007 | 5.03 Million USD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q3 | 25.95 Million USD | -0.87% |
2024 Q1 | 23.64 Million USD | -21.1% |
2024 Q2 | 26.18 Million USD | 10.73% |
2023 Q3 | 22.83 Million USD | 6.04% |
2023 Q2 | 21.53 Million USD | 15.75% |
2023 Q4 | 29.97 Million USD | 31.22% |
2023 Q1 | 18.6 Million USD | -10.6% |
2023 FY | 96.86 Million USD | 40.93% |
2022 Q4 | 20.81 Million USD | 18.83% |
2022 Q2 | 16.89 Million USD | 25.02% |
2022 FY | 68.73 Million USD | 4.25% |
2022 Q1 | 13.51 Million USD | -30.19% |
2022 Q3 | 17.51 Million USD | 3.68% |
2021 Q2 | 17.04 Million USD | 40.08% |
2021 Q1 | 12.17 Million USD | 3.88% |
2021 FY | 65.93 Million USD | 48.15% |
2021 Q3 | 17.36 Million USD | 1.83% |
2021 Q4 | 19.35 Million USD | 11.51% |
2020 Q4 | 11.71 Million USD | -6.44% |
2020 FY | 44.5 Million USD | 28.07% |
2020 Q3 | 12.52 Million USD | 30.35% |
2020 Q1 | 10.66 Million USD | -21.12% |
2020 Q2 | 9.6 Million USD | -9.89% |
2019 Q4 | 13.51 Million USD | 85.66% |
2019 Q2 | 7.71 Million USD | 23.55% |
2019 FY | 34.75 Million USD | 43.02% |
2019 Q1 | 6.24 Million USD | -10.08% |
2019 Q3 | 7.28 Million USD | -5.61% |
2018 Q1 | 4.56 Million USD | -39.59% |
2018 Q4 | 6.94 Million USD | 17.62% |
2018 FY | 24.29 Million USD | -7.39% |
2018 Q3 | 5.9 Million USD | -14.35% |
2018 Q2 | 6.89 Million USD | 51.11% |
2017 Q1 | 6.96 Million USD | -9.52% |
2017 Q4 | 7.55 Million USD | 30.02% |
2017 Q3 | 5.8 Million USD | -1.93% |
2017 FY | 26.23 Million USD | 72.23% |
2017 Q2 | 5.92 Million USD | -14.94% |
2016 FY | 15.23 Million USD | -4.92% |
2016 Q3 | 2.49 Million USD | -43.22% |
2016 Q2 | 4.39 Million USD | 572.89% |
2016 Q1 | 653 Thousand USD | -78.34% |
2016 Q4 | 7.69 Million USD | 208.34% |
2015 Q3 | 4.28 Million USD | -15.97% |
2015 FY | 16.02 Million USD | -11.33% |
2015 Q4 | 3.01 Million USD | -29.62% |
2015 Q2 | 5.09 Million USD | 40.56% |
2015 Q1 | 3.62 Million USD | -30.81% |
2014 Q1 | 3.77 Million USD | 8.46% |
2014 Q2 | 6.94 Million USD | 84.19% |
2014 Q3 | 4.96 Million USD | -28.56% |
2014 Q4 | 5.24 Million USD | 5.66% |
2014 FY | 18.07 Million USD | 16.88% |
2013 Q2 | 3.98 Million USD | 6.36% |
2013 Q3 | 4.26 Million USD | 7.11% |
2013 Q4 | 3.47 Million USD | -18.46% |
2013 FY | 15.46 Million USD | -1.29% |
2013 Q1 | 3.74 Million USD | -28.87% |
2012 Q2 | 2.6 Million USD | 77.02% |
2012 FY | 15.66 Million USD | 472.49% |
2012 Q4 | 5.26 Million USD | 64.72% |
2012 Q1 | 1.47 Million USD | -62.84% |
2012 Q3 | 3.19 Million USD | 22.66% |
2011 FY | -4.2 Million USD | -135.07% |
2011 Q1 | 2 Million USD | -37.91% |
2011 Q2 | 2.69 Million USD | 34.1% |
2011 Q3 | -12.86 Million USD | -578.07% |
2011 Q4 | 3.95 Million USD | 130.79% |
2010 Q2 | 3.27 Million USD | 21.55% |
2010 Q1 | 2.69 Million USD | 240.33% |
2010 Q4 | 3.23 Million USD | 15.52% |
2010 Q3 | 2.79 Million USD | -14.52% |
2010 FY | 11.99 Million USD | 1.84% |
2009 Q2 | 3.81 Million USD | 21.94% |
2009 Q3 | 4.04 Million USD | 6.14% |
2009 FY | 11.77 Million USD | 8.55% |
2009 Q4 | 791 Thousand USD | -80.45% |
2009 Q1 | 3.12 Million USD | -5.27% |
2008 Q4 | 3.3 Million USD | 13.21% |
2008 FY | 10.84 Million USD | 115.37% |
2008 Q3 | 2.91 Million USD | 0.0% |
2007 FY | 5.03 Million USD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Acadia Healthcare Company, Inc. | 506.59 Million USD | 82.046% |
AirSculpt Technologies, Inc. | 9.48 Million USD | -859.148% |
Amedisys, Inc. | 156.39 Million USD | 41.842% |
American Oncology Network, Inc. | -49.15 Million USD | 285.043% |
Astrana Health, Inc. | 84.61 Million USD | -7.496% |
Aveanna Healthcare Holdings Inc. | 8.07 Million USD | -1026.809% |
IMAC Holdings, Inc. | -6.37 Million USD | 1526.647% |
biote Corp. | 28.65 Million USD | -217.395% |
Cryo-Cell International, Inc. | -12.3 Million USD | 839.237% |
Cross Country Healthcare, Inc. | 112.71 Million USD | 19.303% |
COMPASS Pathways plc | -136.91 Million USD | 166.431% |
DocGo Inc. | 15.05 Million USD | -504.159% |
The Ensign Group, Inc. | 255.36 Million USD | 64.382% |
Healthcare Services Group, Inc. | 62.35 Million USD | -45.861% |
InnovAge Holding Corp. | -23.18 Million USD | 492.39% |
Assure Holdings Corp. | -20.08 Million USD | 552.923% |
The Joint Corp. | -2.07 Million USD | 4487.467% |
LifeStance Health Group, Inc. | -189.13 Million USD | 148.091% |
Mobile-health Network Solutions Class A Ordinary Shares | -15.7 Million USD | 679.199% |
ModivCare Inc. | -139.94 Million USD | 164.994% |
NewGenIvf Group Limited | 42.24 Thousand USD | -215221.244% |
Novo Integrated Sciences, Inc. | -8.55 Million USD | 1163.42% |
Option Care Health, Inc. | 314.59 Million USD | 71.088% |
P3 Health Partners Inc. | -167.86 Million USD | 154.186% |
P3 Health Partners Inc. | -167.86 Million USD | 154.186% |
The Pennant Group, Inc. | 25.16 Million USD | -261.381% |
Surgery Partners, Inc. | 328 Million USD | 72.27% |
Syra Health Corp. Class A Common Stock | -2.88 Million USD | 3249.883% |
Talkspace, Inc. | -23.2 Million USD | 491.9% |
Talkspace, Inc. | -23.2 Million USD | 491.9% |
The Oncology Institute, Inc. | -77.01 Million USD | 218.097% |
The Oncology Institute, Inc. | -77.01 Million USD | 218.097% |